BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29413466)

  • 21. Acute visual loss after ipilimumab treatment for metastatic melanoma.
    Wilson MA; Guld K; Galetta S; Walsh RD; Kharlip J; Tamhankar M; McGettigan S; Schuchter LM; Fecher LA
    J Immunother Cancer; 2016; 4():66. PubMed ID: 27777775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ipilimumab for relapse after allogeneic transplantation.
    Baker H
    Lancet Oncol; 2016 Sep; 17(9):e374. PubMed ID: 27452141
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune checkpoint therapy in proteinuric kidney disease.
    Takenaka T; Kawai Y; Amano T
    Eur J Cancer; 2018 May; 95():120-122. PubMed ID: 29530540
    [No Abstract]   [Full Text] [Related]  

  • 24. Ipilimumab prolongs survival in advanced melanoma.
    Burki TK
    Lancet Oncol; 2016 Nov; 17(11):e481. PubMed ID: 27746107
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.
    Lupi I; Cosottini M; Caturegli P; Manetti L; Urbani C; Cappellani D; Scattina I; Martino E; Marcocci C; Bogazzi F
    Eur J Endocrinol; 2017 Aug; 177(2):127-135. PubMed ID: 28626085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary lymphocytic hypophysitis: Clinical characteristics and treatment of 50 cases in a single centre in China over 18 years.
    Wang S; Wang L; Yao Y; Feng F; Yang H; Liang Z; Deng K; You H; Sun J; Xing B; Jin Z; Wang R; Pan H; Zhu H
    Clin Endocrinol (Oxf); 2017 Aug; 87(2):177-184. PubMed ID: 28423475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytic hypophysitis associated with Behcet's disease: A case report and review of the literature.
    Tao T; Zhang Z; Li H
    Neuro Endocrinol Lett; 2018 Mar; 39(1):43-48. PubMed ID: 29803206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Checkpoint Inhibitor-Associated Hypophysitis.
    Chang LS; Yialamas MA
    J Gen Intern Med; 2018 Jan; 33(1):125-127. PubMed ID: 28770379
    [No Abstract]   [Full Text] [Related]  

  • 29. Complete Resolution of the Pituitary Mass Lesion and Improvement of Pituitary Function with Corticosteroid in Autoimmune Hypophysitis: A Case Report.
    Behera KK; Jena RK; Sahoo SK; Soren UK
    Ethiop J Health Sci; 2021 Sep; 31(5):1069-1072. PubMed ID: 35221625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological pituitary hyperplasia misinterpreted and treated as lymphocytic hypophysitis.
    Biswas SN; Barman H; Sarkar TS; Chakraborty PP
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30139788
    [No Abstract]   [Full Text] [Related]  

  • 31. Ipilimumab-Induced Secondary Hypophysitis.
    Cheema A
    Endocr Pract; 2018 Sep; 24(9):854. PubMed ID: 29624100
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune checkpoint inhibitors and endocrinological side effects].
    Jørgensen LB; Bastholt L; Yderstræde K
    Ugeskr Laeger; 2017 Dec; 179(49):. PubMed ID: 29212592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab.
    Brilli L; Danielli R; Ciuoli C; Calabrò L; Di Giacomo AM; Cerase A; Paffetti P; Sestini F; Porcelli B; Maio M; Pacini F
    Endocrine; 2017 Dec; 58(3):535-541. PubMed ID: 28401443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis.
    Chodakiewitz Y; Brown S; Boxerman JL; Brody JM; Rogg JM
    Clin Neurol Neurosurg; 2014 Oct; 125():125-30. PubMed ID: 25127260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cranial diabetes insipidus with pituitary stalk lesions.
    Wijetilleka S; Khan M; Mon A; Sharma D; Joseph F; Sinha A; Das K; Vora J
    QJM; 2016 Nov; 109(11):703-708. PubMed ID: 27131387
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.
    Arangalage D; Delyon J; Lermuzeaux M; Ekpe K; Ederhy S; Pages C; Lebbé C
    Ann Intern Med; 2017 Nov; 167(9):683-684. PubMed ID: 28869988
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilateral ipilimumab-induced posterior uveitis following treatment for metastatic choroidal melanoma.
    Tan AX; Ang A; Campbell WG; Fabinyi DC
    Clin Exp Ophthalmol; 2018 Sep; 46(7):819-821. PubMed ID: 29653019
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acutely induced diabetes mellitus in a 63-year-old female after treatment with ipilimumab for metastatic melanoma].
    Jørgensen LB; Yderstræde K
    Ugeskr Laeger; 2017 Sep; 179(37):. PubMed ID: 28918779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe ipilimumab-induced ulcerative colitis remitting after infliximab therapy and secondary switching with pembrolizumab].
    Yelehe-Okouma M; Granel-Brocard F; Hudziak H; Schmutz JL; Gillet P
    Therapie; 2018; 73(3):291-293. PubMed ID: 29203065
    [No Abstract]   [Full Text] [Related]  

  • 40. Case Records of the Massachusetts General Hospital. Case 31-2016. A 53-Year-Old Man with Diplopia, Polydipsia, and Polyuria.
    Byrne TN; Stone JH; Pillai SS; Rapalino O; Deshpande V
    N Engl J Med; 2016 Oct; 375(15):1469-1480. PubMed ID: 27732818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.